LEVIN JEREMY M

CIK 00012561532 companiesNEW YORK, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001256153

Recent Transactions

50 trades

Exercise/Conversion
Ovid Therapeutics Inc.$OVID
Series A Warrant (right to buy)
2026-03-23−47,333→ 0 total
Exercise/Conversion
Ovid Therapeutics Inc.$OVID
Common Stock
2026-03-23$1.40/sh+47,333→ 3,735,048 total
Award
Ovid Therapeutics Inc.$OVID
Employee Stock Option (Right to Buy)
2026-02-26+957,000→ 957,000 total
Conversion
Ovid Therapeutics Inc.$OVID
Series B Convertible Preferred Stock
2025-12-15−71→ 0 total
Conversion
Ovid Therapeutics Inc.$OVID
Common Stock
2025-12-15+71,000→ 3,687,715 total
Purchase
Ovid Therapeutics Inc.$OVID
Series A Warrant (right to buy)
2025-12-11+47,333→ 47,333 total
Purchase
Ovid Therapeutics Inc.$OVID
Series B Warrant (right to buy)
2025-12-11+35,500→ 35,500 total
Purchase
Ovid Therapeutics Inc.$OVID
Series B Convertible Preferred Stock
2025-12-11+71→ 71 total
Award
Ovid Therapeutics Inc.$OVID
Employee Stock Option (Right to Buy)
2025-02-20+1,650,000→ 1,650,000 total
Purchase
Ovid Therapeutics Inc.$OVID
Common Stock
2024-03-18$2.76/sh+18,248→ 3,616,715 total
Award
Ovid Therapeutics Inc.$OVID
Stock Option (Right to Buy)
2024-02-22+700,000→ 700,000 total
Gift
Ovid Therapeutics Inc.$OVID
Common Stock
2023-12-04−573,275→ 4,171,742 total
Gift
Ovid Therapeutics Inc.$OVID
Common Stock
2023-12-04−573,275→ 3,598,467 total
Award
Ovid Therapeutics Inc.$OVID
Stock Option (Right to Buy)
2023-02-23+600,000→ 600,000 total
Award
Ovid Therapeutics Inc.$OVID
Stock Option (Right to Buy)
2022-04-08+423,244→ 423,244 total
Award
Ovid Therapeutics Inc.$OVID
Stock Option (Right to Buy)
2022-02-03+600,000→ 600,000 total
Award
Ovid Therapeutics Inc.$OVID
Stock Option (Right to Buy)
2020-12-17+650,000→ 650,000 total
Purchase
Ovid Therapeutics Inc.$OVID
Common Stock
2020-08-28$5.84/sh+8,488→ 5,792,530 total
Award
Ovid Therapeutics Inc.$OVID
Stock Option (Right to Buy)
2019-12-18+600,000→ 600,000 total
Purchase
Ovid Therapeutics Inc.$OVID
Common Stock
2019-10-08$2.50/sh+60,000→ 4,736,529 total
Gift
Ovid Therapeutics Inc.$OVID
Common Stock
2019-09-20−465,116→ 0 total
Award
Ovid Therapeutics Inc.$OVID
Employee Stock Option (Right to Buy)
2019-02-24+250,000→ 250,000 total
Purchase
Ovid Therapeutics Inc.$OVID
Common Stock
2019-02-22$2.00/sh+75,000→ 4,676,529 total
Award
Ovid Therapeutics Inc.$OVID
Employee Stock Option (Right to Buy)
2018-01-19+290,000→ 290,000 total
Purchase
Ovid Therapeutics Inc.$OVID
Common Stock
2017-08-25$7.15/sh+15,334→ 4,601,529 total
Conversion
Ovid Therapeutics Inc.$OVID
Common Stock
2017-05-10+400,150→ 4,586,195 total
Conversion
Ovid Therapeutics Inc.$OVID
Common Stock
2017-05-10+35,461→ 35,461 total
Conversion
Ovid Therapeutics Inc.$OVID
Series B Preferred Stock
2017-05-10−35,461→ 0 total
Conversion
Ovid Therapeutics Inc.$OVID
Series A Preferred Stock
2017-05-10−400,150→ 0 total
Tax Payment
BRISTOL MYERS SQUIBB CO$BMY
Common Stock, $0.10 par value
2011-10-01$31.38/sh−4,704→ 43,689 total
Exercise/Conversion
BRISTOL MYERS SQUIBB CO$BMY
Restricted Stock Units
2011-10-01−10,000→ 0 total
Exercise/Conversion
BRISTOL MYERS SQUIBB CO$BMY
Common Stock, $0.10 par value
2011-10-01+10,000→ 48,393 total
Tax Payment
BRISTOL MYERS SQUIBB CO$BMY
Common Stock, $0.10 par value
2011-03-04$26.43/sh−566→ 38,393 total
Exercise/Conversion
BRISTOL MYERS SQUIBB CO$BMY
Restricted Stock Units
2011-03-04−1,397→ 1,397 total
Exercise/Conversion
BRISTOL MYERS SQUIBB CO$BMY
Common Stock, $0.10 par value
2011-03-04+1,397→ 38,959 total
Exercise/Conversion
BRISTOL MYERS SQUIBB CO$BMY
Common Stock, $0.10 par value
2011-03-03+2,019→ 38,380 total
Tax Payment
BRISTOL MYERS SQUIBB CO$BMY
Common Stock, $0.10 par value
2011-03-03$26.14/sh−818→ 37,562 total
Exercise/Conversion
BRISTOL MYERS SQUIBB CO$BMY
Restricted Stock Units
2011-03-03−2,019→ 4,039 total
Exercise/Conversion
BRISTOL MYERS SQUIBB CO$BMY
Common Stock, $0.10 par value
2011-03-02+2,307→ 37,245 total
Exercise/Conversion
BRISTOL MYERS SQUIBB CO$BMY
Market Share Units
2011-03-02−2,307→ 18,233 total
Other
BRISTOL MYERS SQUIBB CO$BMY
Common Stock, $0.10 par value
2011-03-02+84→ 37,329 total
Tax Payment
BRISTOL MYERS SQUIBB CO$BMY
Common Stock, $0.10 par value
2011-03-02$25.39/sh−968→ 36,361 total
Exercise/Conversion
BRISTOL MYERS SQUIBB CO$BMY
Common Stock, $0.10 par value
2011-03-01+12,944→ 40,178 total
Tax Payment
BRISTOL MYERS SQUIBB CO$BMY
Common Stock, $0.10 par value
2011-03-01$25.58/sh−2,324→ 37,854 total
Tax Payment
BRISTOL MYERS SQUIBB CO$BMY
Common Stock, $0.10 par value
2011-03-01$25.58/sh−2,916→ 34,938 total
Award
BRISTOL MYERS SQUIBB CO$BMY
Performance Shares
2011-03-01+5,516→ 5,516 total
Tax Payment
BRISTOL MYERS SQUIBB CO$BMY
Common Stock, $0.10 par value
2011-03-01−2,916→ 34,938 total
Award
BRISTOL MYERS SQUIBB CO$BMY
Performance Shares
2011-03-01+3,898→ 9,414 total
Award
BRISTOL MYERS SQUIBB CO$BMY
Performance Shares
2011-03-01+2,682→ 12,096 total
Exercise/Conversion
BRISTOL MYERS SQUIBB CO$BMY
Performance Shares
2011-03-01−3,898→ 8,479.86 total

Companies

Recent Filings

Address

C/O OVID THERAPEUTICS INC. 441 NINTH AVENUE, 14TH FLOOR

NEW YORK, NY, 10001

View on SEC.gov